JNK2-IN-1
JNK2-IN-1 (Compound J27) is a JNK2 inhibitor (Kds: 79.2 μM) . JNK2-IN-1 has anti-inflammatory activity. JNK2-IN-1 decreases the release of TNF-α and IL-6 through inhibiting the activation of NF-κB/MAPK pathway. JNK2-IN-1 alleviates the symptoms of LPS-induced acute lung injury (ALI) and sepsis[1].
Product Specifications
CAS Number
2998941-15-2
UNSPSC
12352005
Target
JNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jnk2-in-1.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(C=C1)N2C(C=C(C(C(NC3=CC=C(OC4=C5C(C=C(C(OC)=C5)OC)=NC=C4)C=C3)=O)=N2)C)=O
Molecular Formula
C30H26N4O5
Molecular Weight
522.55
References & Citations
[1]Liao J, et al. Discovery of the Diphenyl 6-Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the JNK2-NF-B/MAPK Pathway. J Med Chem. 2023 Aug 29.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B203500-50MG 50 mg
1,3-Benzodioxole-N-phthalimido DL-threo-Droxidopa
Sign In for Pricing
View Details 
